Catalyst
Slingshot members are tracking this event:
FDA Accepts and Grants Priority Review for AVYCAZ (ceftazidime and avibactam) Supplemental New Drug Application (sNDA)
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AGN | Community voting in process | |||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 24, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Avycaz, Ceftazidime, Avibactam, Snda, Caz-ns, Metronidazole, Complicated Intra-abdominal Infections, Ciai, Ceftazidime-nonsusceptible Pathogens
